Researcher

Yuhang Wang

Nanfang Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · JOURNAL ARTICLE

Amplifying Lipid Peroxidation via a Cascade Nanozyme with Lipid Metabolism Reprogramming for Enhanced Chemodynamic Therapy

Acs Applied Bio Materials

This is an early-stage preclinical study demonstrating a novel nanozyme design in cell and animal models without clinical translation, efficacy comparators, or human data.

PreliminaryJingyu Zhou Yuhang Wang Hao Zhang

Study details

DesignPreclinical mechanistic study with in vitro…

InterventionCPA/OA@HA: mesoporous multimetallic nanozym…

AUG 11, 2026 · JOURNAL ARTICLE

Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC

Frontiers in Immunology

Retrospective analysis across multiple cohorts showing associations between intratumoral heterogeneity and immunotherapy response and recurrence, but limited by observational design, lack of prospective validation, and surrogate endpoints rather than hard clinical outcomes.

PromisingRadiomics and Machine Learning in Medical Imaging Haofei Wang Yuhang Wang

Reported

Sample size (advanced NSCLC immun…504

Sample size (early-stage surgical…121

NGS testing panel scope (surgical…733-panel